Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

Journal of Crohn's and Colitis

Volumn 5, Issue 5, 2011, Pages 402-406

  Yilmaz, Y ^a   Yonal, O ^a   Eren, F ^a   Atug, O ^a   Over Hamzaoglu, H ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Crohn's disease; Enzyme linked immunosorbent assay; Receptor for advanced glycation endproducts (RAGE); Ulcerative colitis

Indexed keywords

ADALIMUMAB; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BIOLOGICAL THERAPY; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEPTORS, IMMUNOLOGIC;

EID: 80053131108     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.03.011     Document Type: Article

References (22)

1. Lin L., Park S., Lakatta E.G. RAGE signaling in inflammation and arterial aging. Front Biosci 2009, 14:1403-1413.
2. Chavakis T., Bierhaus A., Nawroth P.P. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 2004, 6:1219-1225.
3. Stern D., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002, 54:1615-1625.
4. Geroldi D., Falcone C., Emanuele E. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem 2006, 13:1971-1978.
5. Hudson B.I., Carter A.M., Harja E., Kalea A.Z., Arriero M., Yang H., Grant P.J., Schmidt A.M. Identification, classification, and expression of RAGE gene splice variants. FASEB J 2008, 22:1572-1580.
6. Koyama H., Yamamoto H., Nishizawa Y. Endogenous secretory RAGE as a novel biomarker for metabolic syndrome and cardiovascular diseases. Biomark Insights 2007, 2:331-339.
7. Humpert P.M., Djuric Z., Kopf S., Rudofsky G., Morcos M., Nawroth PP., Bierhaus A. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes. Cardiovasc Diabetol 2007, 6:9.
8. Foell D., Kucharzik T., Kraft M., Vogl T., Sorg C., Domschke W., Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003, 52:847-853.
9. Andrassy M., Igwe J., Autschbach F., Volz C., Remppis A., Neurath M.F., Schleicher E., Humpert P.M., Wendt T., Liliensiek B., Morcos M., Schiekofer S., Thiele K., Chen J., Kientsch-Engel R., Schmidt A.M., Stremmel W., Stern D.M., Katus H.A., Nawroth P.P., Bierhaus A. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 2006, 169:1223-1237.
10. Zen K., Chen C.X., Chen Y.T., Wilton R., Liu Y. Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 2007, 178:2483-2490.
11. Cirillo C., Sarnelli G., Esposito G., Grosso M., Petruzzelli R., Izzo P., Calì G., D'Armiento F.P., Rocco A., Nardone G., Iuvone T., Steardo L., Cuomo R. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil 2009, 21:1209-1212.
12. Leach S.T., Yang Z., Messina I., Song C., Geczy C.L., Cunningham A.M., Day A.S. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 2007, 42:1321-1331.
13. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus E.V., Peña A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19:5-36.
14. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
15. Seo M., Okada M., Yao T., Ueki M., Arima S., Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992, 87:971-976.
16. Leclerc E., Fritz G., Vetter S.W., Heizmann C.W. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 2009, 1793:993-1007.
17. Zhang L., Bukulin M., Kojro E., Roth A., Metz V.V., Fahrenholz F., Nawroth P.P., Bierhaus A., Postina R. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 2008, 283:35507-35516.
18. Raucci A., Cugusi S., Antonelli A., Barabino S.M., Monti L., Bierhaus A., Reiss K., Saftig P., Bianchi M.E. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008, 22:3716-3727.
19. Wang Y.D., Mao J.W. Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis. World J Gastroenterol 2007, 13:5926-5932.
20. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83:876-886.
21. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
22. Hudson B.I., Moon Y.P., Kalea A.Z., Khatri M., Marquez C., Schmidt A.M., Paik M.C., Yoshita M., Sacco R.L., Decarli C., Wright C.B., Elkind M.S. Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS). Atherosclerosis 2011, 10.1016/j.atherosclerosis.2011.01.024.